Guidance for choosing SARS-CoV-2 LOINC terms
Watch our March 2020 SARS-CoV-2/ COVID-19 webinar
This page contains LOINC terms that are related to SARS coronavirus 2 (SARS-CoV-2) and COVID-19. We are providing this page as a single source for all SARS-CoV-2/COVID-19 LOINC content. Note that the contents will be updated as new terms are created and pre-released, so check back frequently for the latest contents.
This page contains both published and pre-release terms.
- Published terms have the code highlighted in blue and contain the version in which the term was first published in the Version column;
- Pre-release terms have the code highlighted in yellow, and the Version column is empty.
Some of the terms, such as the lab terms, are specific to SARS-CoV-2/COVID-19, and some, such as the telehealth document codes, are related to the current pandemic but can also be used in different contexts. These terms will help support the HHS COVID-19 Pandemic Response, Laboratory Data Reporting: CARES Act Section 18115Â requirements.
All terms were created based on requests from LOINC users. We have been working closely with APHL, CDC, FDA, labs, IVD manufacturers, and other stakeholders on the codes specifically related to SARS-CoV-2/COVID-19. To obtain the current list of LOINC mappings to SARS-CoV-2 IVD assays approved for FDA EUA, you can download the LIVD file posted on the CDC website.
Exporting data
You can download the contents of this page in .csv format. If you filter the contents, only the remaining terms will be included in the download file. In order to download you must be logged in, so that we can keep track of usage and also so that we can contact you if there is an issue with the format or contents of the file that you downloaded. The contents on this page are not static and will be automatically updated when new SARS-CoV-2/COVID-19 terms are pre-released.
Important notice regarding pre-release content
Pre-release terms are those which have not yet been published in a public release. They are also available on the LOINC pre-release page. Once they are published, they will no longer be on the pre-release page, but will still be included on this page with the appropriate Version value.
If you need to include a version when you are using one of the pre-release codes, we recommend using the following: {Version of the upcoming LOINC release}-pre. For example, the June 2021 LOINC release will be release 2.70. The version of pre-release codes published between the 2.69 release in December 2020 and 2.70 is 2.70-pre.
These SARS-CoV-2/COVID-19 codes are based on the most up to date information available at the time of their creation and they have undergone the normal QA terminology process. LOINC supports their use in the unique situation that resulted in their rapid creation.
Be aware that downstream users may not be ready to handle prerelease codes until they are published in an official release.
SARS CoV 2 lab tests
VersionFirstReleased | LOINC_NUM | Long Common Name | Component | Property | Time_Aspct | System | Scale_Typ | Method_Typ | Class | ClassType | Shortname | External_Copyright_Notice | Status | VersionLastChanged |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2.68 | 94508-9 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | SARS coronavirus 2 Ab.IgM | PrThr | Pt | Ser/Plas/Bld | Ord | IA.rapid | MICRO | 1 | SARS-CoV-2 IgM SerPlBld Ql IA.rapid | ACTIVE | 2.69 | |
2.68 | 94532-9 | SARS-related coronavirus+MERS coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection | SARS-related coronavirus+ |
PrThr | Pt | Respiratory | Ord | Probe.amp.tar | MICRO | 1 | SARS-rel CoV+MERS RNA Resp Ql NAA+probe | ACTIVE | 2.68 | |
2.68 | 94533-7 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 N gene | PrThr | Pt | Respiratory | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene Resp Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94562-6 | SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab.IgA | PrThr | Pt | Ser/Plas | Ord | IA | MICRO | 1 | SARS-CoV-2 IgA SerPl Ql IA | ACTIVE | 2.69 | |
2.69 | 95427-1 | SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence | SARS coronavirus 2 Ab.IgA | Titr | Pt | Ser/Plas | Qn | IF | MICRO | 1 | SARS-CoV-2 IgA Titr SerPl IF | ACTIVE | 2.69 | |
2.68 | 94660-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detection | SARS coronavirus 2 RNA | PrThr | Pt | Ser/Plas | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA SerPl Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94720-0 | SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab.IgA | ACnc | Pt | Ser/Plas | Qn | IA | MICRO | 1 | SARS-CoV-2 IgA SerPl IA-aCnc | ACTIVE | 2.69 | |
2.68 | 94822-4 | SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by Sequencing | SARS coronavirus 2 RNA | PrThr | Pt | Saliva | Ord | Sequencing | MICRO | 1 | SARS-CoV-2 RNA Sal Ql Seq | ACTIVE | 2.69 | |
96957-6 | SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection | SARS coronavirus 2 M gene | PrThr | Pt | Respiratory.upper | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 M gene Upper resp Ql NAA+prob | ACTIVE | |||
97097-0 | SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay | SARS coronavirus 2 Ag | PrThr | Pt | Respiratory.upper | Ord | IA.rapid | MICRO | 1 | SARS-CoV-2 Ag Upper resp Ql IA.rapid | ACTIVE | |||
96829-7 | SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen from Donor by NAA with probe detection | SARS coronavirus 2 RNA | PrThr | Pt | XXX^Donor | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Spec Donr Ql NAA+probe | ACTIVE | |||
2.68 | 94769-7 | SARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab | ACnc | Pt | Ser/Plas | Qn | IA | MICRO | 1 | SARS-CoV-2 Ab SerPl IA-aCnc | ACTIVE | 2.69 | |
2.68 | 94746-5 | SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Specimen by NAA with probe detection | SARS coronavirus 2 RNA | ThreshNum | Pt | XXX | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Ct Spec Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94745-7 | SARS-CoV-2 (COVID-19) RNA [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 RNA | ThreshNum | Pt | Respiratory | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Ct Resp Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94647-5 | SARS-related coronavirus RNA [Presence] in Specimen by NAA with probe detection | SARS-related coronavirus RNA | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARSr-CoV RNA Spec Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94646-7 | SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 RdRp gene | ThreshNum | Pt | Respiratory | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RdRp Ct Resp Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94645-9 | SARS-CoV-2 (COVID-19) RdRp gene [Cycle Threshold #] in Specimen by NAA with probe detection | SARS coronavirus 2 RdRp gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RdRp Ct Spec Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94639-2 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Specimen by NAA with probe detection | SARS coronavirus 2 ORF1ab region | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 ORF1ab Spec Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94547-7 | SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab.IgG+ |
PrThr | Pt | Ser/Plas | Ord | IA | MICRO | 1 | SARS-CoV-2 IgG+IgM SerPl Ql IA | ACTIVE | 2.69 | |
2.68 | 94511-3 | SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Specimen by NAA with probe detection | SARS coronavirus 2 ORF1ab region | ThreshNum | Pt | XXX | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 ORF1ab Ct Spec Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94314-2 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection | SARS coronavirus 2 RdRp gene | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RdRp Spec Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94313-4 | SARS-like coronavirus N gene [Cycle Threshold #] in Specimen by NAA with probe detection | SARS-like coronavirus N gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar | MICRO | 1 | SARS-like CoV N Ct Spec Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94312-6 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N2 | SARS coronavirus 2 N gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar.CDC primer-probe set N2 | MICRO | 1 | SARS-CoV-2 N gene Ct Spec Qn NAA N2 | ACTIVE | 2.69 | |
2.68 | 94311-8 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by Nucleic acid amplification using CDC primer-probe set N1 | SARS coronavirus 2 N gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar.CDC primer-probe set N1 | MICRO | 1 | SARS-CoV-2 N gene Ct Spec Qn NAA N1 | ACTIVE | 2.69 | |
2.68 | 94310-0 | SARS-like coronavirus N gene [Presence] in Specimen by NAA with probe detection | SARS-like coronavirus N gene | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-like CoV N Spec Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94309-2 | SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection | SARS coronavirus 2 RNA | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Spec Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94308-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N2 | SARS coronavirus 2 N gene | PrThr | Pt | XXX | Ord | Probe.amp.tar.CDC primer-probe set N2 | MICRO | 1 | SARS-CoV-2 N gene Spec Ql NAA N2 | ACTIVE | 2.69 | |
2.68 | 94307-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by Nucleic acid amplification using CDC primer-probe set N1 | SARS coronavirus 2 N gene | PrThr | Pt | XXX | Ord | Probe.amp.tar.CDC primer-probe set N1 | MICRO | 1 | SARS-CoV-2 N gene Spec Ql NAA N1 | ACTIVE | 2.69 | |
2.69 | 96094-8 | SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection | SARS coronavirus 2 & SARS-related coronavirus RNA panel | - | Pt | Respiratory | - | Probe.amp.tar | PANEL.MICRO | 1 | SARS-CoV-2+SARSr-CoV pnl Resp NAA+probe | ACTIVE | 2.69 | |
2.69 | 95942-9 | Influenza virus A and B and SARS-CoV+SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay | Influenza virus A & Influenza virus B & SARS coronavirus+ |
- | Pt | Respiratory.upper | - | IA.rapid | PANEL.MICRO | 1 | FLUABV+SARS-CoV Ag Pnl Up resp IA.rapid | ACTIVE | 2.69 | |
2.69 | 95941-1 | Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory specimen by NAA with probe detection | Influenza virus A & Influenza virus B & SARS coronavirus 2 & Respiratory syncytial virus RNA panel | - | Pt | Respiratory | - | Probe.amp.tar | PANEL.MICRO | 1 | FLUABV+SARS-CoV-2+RSV Pnl Resp NAA+probe | ACTIVE | 2.69 | |
2.69 | 95974-2 | SARS-CoV-2 stimulated gamma interferon panel - Blood | SARS coronavirus 2 stimulated gamma interferon panel | - | Pt | Bld | - | PANEL.MICRO | 1 | SARS-CoV-2 IFN-g Pnl Bld | ACTIVE | 2.70 | ||
2.69 | 95973-4 | SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] in Blood | SARS coronavirus 2 stimulated gamma interferon release by T-cells | ACnc | Pt | Bld | Qn | MICRO | 1 | SARS-CoV-2 IFN-g T cells Bld-aCnc | ACTIVE | 2.70 | ||
2.69 | 95972-6 | SARS-CoV-2 stimulated gamma interferon release by T-cells [Units/volume] corrected for background in Blood | SARS coronavirus 2 stimulated gamma interferon release by T-cells^^corrected for background | ACnc | Pt | Bld | Qn | MICRO | 1 | SARS CoV-2 IFN-g Tcel bkgrd cor Bld-aCnc | ACTIVE | 2.70 | ||
2.69 | 95971-8 | SARS-CoV-2 stimulated gamma interferon [Presence] in Blood | SARS coronavirus 2 stimulated gamma interferon | PrThr | Pt | Bld | Ord | MICRO | 1 | SARS-CoV-2 IFN-g Bld Ql | ACTIVE | 2.70 | ||
2.69 | 95970-0 | SARS-CoV-2 (COVID-19) specific TCRB gene rearrangements [Presence] in Blood by Sequencing | SARS coronavirus 2 specific TCRB gene rearrangements | PrThr | Pt | Bld | Ord | Sequencing | MICRO | 1 | SARS-CoV-2 TCRB Bld Ql Seq | ACTIVE | 2.69 | |
2.69 | 95825-6 | SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay | SARS coronavirus 2 Ab | PrThr | Pt | Bld.dot | Ord | IA | MICRO | 1 | SARS-CoV-2 Ab DBS Ql IA | ACTIVE | 2.69 | |
2.69 | 96123-5 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Upper respiratory specimen by NAA with probe detection | SARS coronavirus 2 RdRp gene | PrThr | Pt | Respiratory.upper | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RdRp Upper resp Ql NAA+probe | ACTIVE | 2.69 | |
2.69 | 96122-7 | SARS-related coronavirus E gene [Presence] in Upper respiratory specimen by NAA with probe detection | SARS-related coronavirus E gene | PrThr | Pt | Respiratory.upper | Ord | Probe.amp.tar | MICRO | 1 | SARS-rel CoV E gene Upper resp Ql NAA+prb | ACTIVE | 2.69 | |
2.69 | 95522-9 | SARS-CoV-2 (COVID-19) N gene [Log #/volume] (viral load) in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 N gene | LnCnc | Pt | Respiratory | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene Resp NAA+probe-Log# | ACTIVE | 2.69 | |
2.69 | 95521-1 | SARS-CoV-2 (COVID-19) N gene [#/volume] (viral load) in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 N gene | NCnc | Pt | Respiratory | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene # Resp NAA+probe | ACTIVE | 2.69 | |
2.69 | 96121-9 | SARS-related coronavirus E gene [Presence] in Lower respiratory specimen by NAA with probe detection | SARS-related coronavirus E gene | PrThr | Pt | Respiratory.lower | Ord | Probe.amp.tar | MICRO | 1 | SARS-rel CoV E gene Low resp Ql NAA+prb | ACTIVE | 2.69 | |
2.68 | 95411-5 | SARS-CoV-2 (COVID-19) neutralizing antibody [Presence] in Serum by pVNT | SARS coronavirus 2 Ab.neut | PrThr | Pt | Ser | Ord | pVNT | MICRO | 1 | SARS-CoV-2 NAb Ser Ql pVNT | ACTIVE | 2.69 | |
2.68 | 95410-7 | SARS-CoV-2 (COVID-19) neutralizing antibody [Titer] in Serum by pVNT | SARS coronavirus 2 Ab.neut | Titr | Pt | Ser | Qn | pVNT | MICRO | 1 | SARS-CoV-2 NAb Titr Ser pVNT | ACTIVE | 2.69 | |
2.68 | 95409-9 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with probe detection | SARS coronavirus 2 N gene | PrThr | Pt | Nose | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene Nose Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 95406-5 | SARS-CoV-2 (COVID-19) RNA [Presence] in Nose by NAA with probe detection | SARS coronavirus 2 RNA | PrThr | Pt | Nose | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Nose Ql NAA+probe | ACTIVE | 2.69 | |
2.69 | 96120-1 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Lower respiratory specimen by NAA with probe detection | SARS coronavirus 2 RdRp gene | PrThr | Pt | Respiratory.lower | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RdRp Lower resp Ql NAA+probe | ACTIVE | 2.69 | |
2.69 | 95826-4 | SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection | SARS coronavirus 2 RNA panel | - | Pt | Saliva | - | Probe.amp.tar | PANEL.MICRO | 1 | SARS-CoV-2 RNA Pnl Sal NAA+probe | ACTIVE | 2.69 | |
2.69 | 96119-3 | SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay | SARS coronavirus 2 Ag | PrThr | Pt | Respiratory.upper | Ord | IA | MICRO | 1 | SARS-CoV-2 Ag Upper resp Ql IA | ACTIVE | 2.69 | |
2.69 | 96118-5 | SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay | SARS coronavirus 2 Ab panel | - | Pt | Bld.dot | - | IA | PANEL.MICRO | 1 | SARS-CoV-2 Ab Pnl DBS IA | ACTIVE | 2.69 | |
2.69 | 95609-4 | SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by Sequencing | SARS coronavirus 2 S gene | PrThr | Pt | Respiratory | Ord | Sequencing | MICRO | 1 | SARS-CoV-2 S gene Resp Ql Seq | ACTIVE | 2.69 | |
2.69 | 95608-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with non-probe detection | SARS coronavirus 2 RNA | PrThr | Pt | Respiratory | Ord | Non-probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Resp Ql NAA+non-probe | ACTIVE | 2.69 | |
2.68 | 95209-3 | SARS-CoV+SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay | SARS coronavirus+ |
PrThr | Pt | Respiratory | Ord | IA.rapid | MICRO | 1 | SARS-CoV+SARS-CoV-2 Ag Resp Ql IA.rapid | ACTIVE | 2.69 | |
2.68 | 95125-1 | SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab.IgA+ |
PrThr | Pt | Ser/Plas | Ord | IA | MICRO | 1 | SARS-CoV-2 IgA+IgM SerPl Ql IA | ACTIVE | 2.69 | |
2.69 | 96448-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1 | SARS coronavirus 2 N gene | PrThr | Pt | Saliva | Ord | Probe.amp.tar.CDC primer-probe set N1 | MICRO | 1 | SARS-CoV-2 N gene Sal Ql NAA N1 | ACTIVE | 2.69 | |
2.69 | 96603-6 | SARS-CoV-2 (COVID-19) S protein RBD neutralizing antibody [Presence] in Serum or Plasma by Immunoassay | SARS coronavirus 2 spike protein RBD Ab.neut | PrThr | Pt | Ser/Plas | Ord | IA | MICRO | 1 | SARS-CoV-2 S RBD NAb SerPl Ql IA | ACTIVE | 2.69 | |
2.69 | 95824-9 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS coronavirus 2 ORF1ab region | PrThr | Pt | Saliva | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 ORF1ab Sal Ql NAA+probe | ACTIVE | 2.69 | |
2.69 | 95823-1 | SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS-related coronavirus E gene | PrThr | Pt | Saliva | Ord | Probe.amp.tar | MICRO | 1 | SARS-rel CoV E gene Sal Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 95416-4 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay | SARS coronavirus 2 Ab.IgM | PrThr | Pt | Bld.dot | Ord | IA | MICRO | 1 | SARS-CoV-2 IgM DBS Ql IA | ACTIVE | 2.69 | |
2.69 | 95542-7 | SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | SARS coronavirus 2 Ab.IgG+ |
PrThr | Pt | Ser/Plas/Bld | Ord | IA.rapid | MICRO | 1 | SARS-CoV-2 IgG+IgM SerPlBld Ql IA.rapid | ACTIVE | 2.69 | |
2.69 | 95425-5 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS coronavirus 2 N gene | PrThr | Pt | Saliva | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene Sal Ql NAA+probe | ACTIVE | 2.69 | |
2.69 | 95424-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by Sequencing | SARS coronavirus 2 RNA | PrThr | Pt | Respiratory | Ord | Sequencing | MICRO | 1 | SARS-CoV-2 RNA Resp Ql Seq | ACTIVE | 2.69 | |
2.69 | 95423-0 | Influenza virus A and B and SARS-CoV-2 (COVID-19) identified in Respiratory specimen by NAA with probe detection | Influenza virus A & Influenza virus B & SARS coronavirus 2 identified | Prid | Pt | Respiratory | Nom | Probe.amp.tar | MICRO | 1 | FLUABV + SARS-CoV-2 Resp NAA+probe | ACTIVE | 2.69 | |
2.69 | 95422-2 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection | Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel | - | Pt | Respiratory | - | Probe.amp.tar | PANEL.MICRO | 1 | FLUABV + SARS-CoV-2 Pnl Resp NAA+prb | ACTIVE | 2.69 | |
2.69 | 95429-7 | SARS-CoV-2 (COVID-19) IgG Ab [Titer] in Serum or Plasma by Immunofluorescence | SARS coronavirus 2 Ab.IgG | Titr | Pt | Ser/Plas | Qn | IF | MICRO | 1 | SARS-CoV-2 IgG Titr SerPl IF | ACTIVE | 2.69 | |
2.69 | 95380-2 | Influenza virus A and B and SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Respiratory specimen by NAA with probe detection | Influenza virus A & Influenza virus B & SARS coronavirus 2 & SARS-related coronavirus RNA panel | - | Pt | Respiratory | - | Probe.amp.tar | PANEL.MICRO | 1 | FluAB+SARS-CoV-2+SARSr-CoV Resp NAA+prb | ACTIVE | 2.69 | |
2.69 | 96091-4 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS coronavirus 2 RdRp gene | PrThr | Pt | Saliva | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RdRp Sal Ql NAA+probe | ACTIVE | 2.69 | |
2.69 | 95428-9 | SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence | SARS coronavirus 2 Ab.IgM | Titr | Pt | Ser/Plas | Qn | IF | MICRO | 1 | SARS-CoV-2 IgM Titr SerPl IF | ACTIVE | 2.69 | |
2.68 | 94565-9 | SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with non-probe detection | SARS coronavirus 2 RNA | PrThr | Pt | Nph | Ord | Non-probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Nph Ql NAA+non-probe | ACTIVE | 2.69 | |
2.68 | 94510-5 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Specimen by NAA with probe detection | SARS coronavirus 2 N gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene Ct Spec Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94509-7 | SARS-related coronavirus E gene [Cycle Threshold #] in Specimen by NAA with probe detection | SARS-related coronavirus E gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar | MICRO | 1 | SARS-rel CoV E gene Ct Spec Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94507-1 | SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | SARS coronavirus 2 Ab.IgG | PrThr | Pt | Ser/Plas/Bld | Ord | IA.rapid | MICRO | 1 | SARS-CoV-2 IgG SerPlBld Ql IA.rapid | ACTIVE | 2.69 | |
2.68 | 94506-3 | SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab.IgM | ACnc | Pt | Ser/Plas | Qn | IA | MICRO | 1 | SARS-CoV-2 IgM SerPl IA-aCnc | ACTIVE | 2.69 | |
2.68 | 94505-5 | SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab.IgG | ACnc | Pt | Ser/Plas | Qn | IA | MICRO | 1 | SARS-CoV-2 IgG SerPl IA-aCnc | ACTIVE | 2.69 | |
2.68 | 94504-8 | SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab panel | - | Pt | Ser/Plas | - | IA | PANEL.MICRO | 1 | SARS-CoV-2 Ab Pnl SerPl IA | ACTIVE | 2.69 | |
2.68 | 94503-0 | SARS-CoV-2 (COVID-19) Ab panel - Serum, Plasma or Blood by Rapid immunoassay | SARS coronavirus 2 Ab panel | - | Pt | Ser/Plas/Bld | - | IA.rapid | PANEL.MICRO | 1 | SARS-CoV-2 Ab Pnl SerPlBld IA.rapid | ACTIVE | 2.69 | |
2.68 | 94502-2 | SARS-related coronavirus RNA [Presence] in Respiratory specimen by NAA with probe detection | SARS-related coronavirus RNA | PrThr | Pt | Respiratory | Ord | Probe.amp.tar | MICRO | 1 | SARS-rel CoV RNA Resp Ql NAA+probe | ACTIVE | 2.68 | |
2.68 | 94500-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 RNA | PrThr | Pt | Respiratory | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Resp Ql NAA+probe | ACTIVE | 2.69 | |
96755-4 | SARS-CoV-2 (COVID-19) variant interpretation in Specimen Narrative | SARS coronavirus 2 variant interpretation | Imp | Pt | XXX | Nar | MICRO | 1 | SARS-CoV-2 variant Imp Spec | ACTIVE | ||||
2.68 | 94762-2 | SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab | PrThr | Pt | Ser/Plas | Ord | IA | MICRO | 1 | SARS-CoV-2 Ab SerPl Ql IA | ACTIVE | 2.69 | |
2.68 | 94761-4 | SARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by Immunoassay | SARS coronavirus 2 Ab.IgG | PrThr | Pt | Bld.dot | Ord | IA | MICRO | 1 | SARS-CoV-2 IgG DBS Ql IA | ACTIVE | 2.69 | |
2.68 | 94758-0 | SARS-related coronavirus E gene [Presence] in Respiratory specimen by NAA with probe detection | SARS-related coronavirus E gene | PrThr | Pt | Respiratory | Ord | Probe.amp.tar | MICRO | 1 | SARS-rel CoV E gene Resp Ql NAA+probe | ACTIVE | 2.68 | |
2.68 | 94757-2 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N2 | SARS coronavirus 2 N gene | PrThr | Pt | Respiratory | Ord | Probe.amp.tar.CDC primer-probe set N2 | MICRO | 1 | SARS-CoV-2 N gene Resp Ql NAA N2 | ACTIVE | 2.69 | |
2.68 | 94756-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Respiratory specimen by Nucleic acid amplification using CDC primer-probe set N1 | SARS coronavirus 2 N gene | PrThr | Pt | Respiratory | Ord | Probe.amp.tar.CDC primer-probe set N1 | MICRO | 1 | SARS-CoV-2 N gene Resp Ql NAA N1 | ACTIVE | 2.69 | |
2.68 | 94644-2 | SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 ORF1ab region | ThreshNum | Pt | Respiratory | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 ORF1ab Ct Resp Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94643-4 | SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Specimen by NAA with probe detection | SARS coronavirus 2 S gene | ThreshNum | Pt | XXX | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 S gene Ct Spec Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94642-6 | SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 S gene | ThreshNum | Pt | Respiratory | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 S gene Ct Resp Qn NAA+probe | ACTIVE | 2.69 | |
2.68 | 94564-2 | SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab.IgM | PrThr | Pt | Ser/Plas | Ord | IA | MICRO | 1 | SARS-CoV-2 IgM SerPl Ql IA | ACTIVE | 2.69 | |
2.68 | 94563-4 | SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab.IgG | PrThr | Pt | Ser/Plas | Ord | IA | MICRO | 1 | SARS-CoV-2 IgG SerPl Ql IA | ACTIVE | 2.69 | |
2.68 | 94534-5 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 RdRp gene | PrThr | Pt | Respiratory | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RdRp Resp Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94531-1 | SARS-CoV-2 (COVID-19) RNA panel - Respiratory specimen by NAA with probe detection | SARS coronavirus 2 RNA panel | - | Pt | Respiratory | - | Probe.amp.tar | PANEL.MICRO | 1 | SARS-CoV-2 RNA Pnl Resp NAA+probe | ACTIVE | 2.69 | |
2.68 | 94316-7 | SARS-CoV-2 (COVID-19) N gene [Presence] in Specimen by NAA with probe detection | SARS coronavirus 2 N gene | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene Spec Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94315-9 | SARS-related coronavirus E gene [Presence] in Specimen by NAA with probe detection | SARS-related coronavirus E gene | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-rel CoV E gene Spec Ql NAA+probe | ACTIVE | 2.69 | |
96763-8 | SARS-CoV-2 (COVID-19) E gene [Presence] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 E gene | PrThr | Pt | Respiratory | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 E gene Resp Ql NAA+probe | ACTIVE | |||
96752-1 | SARS-CoV-2 (COVID-19) S gene mutation [Presence] in Specimen by Molecular genetics method | SARS coronavirus 2 S gene mutation | PrThr | Pt | XXX | Ord | Molgen | MICRO | 1 | SARS-CoV-2 S gene mut Spec Ql | ACTIVE | |||
96751-3 | SARS-CoV-2 (COVID-19) S gene mutation detected [Identifier] in Specimen by Molecular genetics method | SARS coronavirus 2 S gene mutation detected | Prid | Pt | XXX | Nom | Molgen | MICRO | 1 | SARS-CoV-2 S gene mut Spec | ACTIVE | |||
97099-6 | Influenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel - Upper respiratory specimen by Rapid immunoassay | Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag panel | - | Pt | Respiratory.upper | - | IA.rapid | PANEL.MICRO | 1 | FLUABV+SARS-CoV2 Ag Pnl Up resp IA.rapid | ACTIVE | |||
97098-8 | SARS-CoV-2 (COVID-19) Nsp2 gene [Presence] in Upper respiratory specimen by NAA with probe detection | SARS coronavirus 2 Nsp2 gene | PrThr | Pt | Respiratory.upper | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 Nsp2 Upper resp Ql NAA+probe | ACTIVE | |||
96896-6 | SARS-CoV-2 (COVID-19) clade [Type] in Specimen by Molecular genetics method | SARS coronavirus 2 clade | Type | Pt | XXX | Nom | Molgen | MICRO | 1 | SARS-CoV-2 clade Spec | ACTIVE | |||
96895-8 | SARS-CoV-2 (COVID-19) lineage [Identifier] in Specimen by Molecular genetics method | SARS coronavirus 2 lineage | Prid | Pt | XXX | Nom | Molgen | MICRO | 1 | SARS-CoV-2 lineage Spec | ACTIVE | |||
96894-1 | SARS-CoV-2 (COVID-19) whole genome sequencing and identification panel - Specimen by Molecular genetics method | SARS coronavirus 2 whole genome sequencing & identification panel | - | Pt | XXX | - | Molgen | PANEL.MICRO | 1 | SARS-CoV-2 Seq and ID Pnl Spec | ACTIVE | |||
96958-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2 | SARS coronavirus 2 N gene | PrThr | Pt | Saliva | Ord | Probe.amp.tar.CDC primer-probe set N2 | MICRO | 1 | SARS-CoV-2 N gene Sal Ql NAA N2 | ACTIVE | |||
96986-5 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection | SARS coronavirus 2 N gene | PrThr | Pt | Nose | Ord | Non-probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene Nose Ql NAA+non-probe | ACTIVE | |||
96900-6 | SARS-CoV-2 (COVID-19) S gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection | SARS coronavirus 2 S gene | ThreshNum | Pt | Oropharyngeal wash | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 S gene Ct OPA wash Qn NAA+prb | ACTIVE | |||
96899-0 | SARS-CoV-2 (COVID-19) ORF1ab region [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection | SARS coronavirus 2 ORF1ab region | ThreshNum | Pt | Oropharyngeal wash | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 ORF1ab Ct OPA wash Qn NAA+prb | ACTIVE | |||
96898-2 | SARS-CoV-2 (COVID-19) N gene [Cycle Threshold #] in Oropharyngeal wash by NAA with probe detection | SARS coronavirus 2 N gene | ThreshNum | Pt | Oropharyngeal wash | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene Ct OPA wash Qn NAA+prb | ACTIVE | |||
96897-4 | SARS-CoV-2 (COVID-19) RNA panel - Oropharyngeal wash by NAA with probe detection | SARS coronavirus 2 RNA panel | - | Pt | Oropharyngeal wash | - | Probe.amp.tar | PANEL.MICRO | 1 | SARS-CoV-2 RNA Pnl OPA wash NAA+probe | ACTIVE | |||
2.68 | 94845-5 | SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS coronavirus 2 RNA | PrThr | Pt | Saliva | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Sal Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94819-0 | SARS-CoV-2 (COVID-19) RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection | SARS coronavirus 2 RNA | LnCnc | Pt | XXX | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Spec NAA+probe-Log# | ACTIVE | 2.69 | |
96764-6 | SARS-CoV-2 (COVID-19) E gene [Cycle Threshold #] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 E gene | ThreshNum | Pt | Respiratory | Qn | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 E gene Ct Resp Qn NAA+probe | ACTIVE | |||
96765-3 | SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection | SARS coronavirus 2 S gene | PrThr | Pt | Saliva | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 S gene Sal Ql NAA+probe | ACTIVE | |||
96766-1 | GISAID sequence accession number | GISAID sequence accession number | ID | Pt | Isolate | Nom | MICRO | 1 | GISAID seq accession ID | ACTIVE | ||||
96741-4 | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by Sequencing | SARS coronavirus 2 variant | Type | Pt | XXX | Nom | Sequencing | MICRO | 1 | SARS-CoV-2 variant Spec Seq | ACTIVE | |||
96742-2 | SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay | SARS coronavirus 2 Ab.IgG | MCnc | Pt | Ser/Plas | Qn | IA | MICRO | 1 | SARS-CoV-2 IgG SerPl IA-mCnc | ACTIVE | |||
2.68 | 94768-9 | SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay | SARS coronavirus 2 Ab.IgA | PrThr | Pt | Ser/Plas/Bld | Ord | IA.rapid | MICRO | 1 | SARS-CoV-2 IgA SerPlBld Ql IA.rapid | ACTIVE | 2.69 | |
2.68 | 94767-1 | SARS-CoV-2 (COVID-19) S gene [Presence] in Serum or Plasma by NAA with probe detection | SARS coronavirus 2 S gene | PrThr | Pt | Ser/Plas | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 S gene SerPl Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94766-3 | SARS-CoV-2 (COVID-19) N gene [Presence] in Serum or Plasma by NAA with probe detection | SARS coronavirus 2 N gene | PrThr | Pt | Ser/Plas | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene SerPl Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94765-5 | SARS-related coronavirus E gene [Presence] in Serum or Plasma by NAA with probe detection | SARS-related coronavirus E gene | PrThr | Pt | Ser/Plas | Ord | Probe.amp.tar | MICRO | 1 | SARS-rel CoV E gene SerPl Ql NAA+probe | ACTIVE | 2.68 | |
2.68 | 94764-8 | SARS-CoV-2 (COVID-19) whole genome [Nucleotide sequence] in Isolate or Specimen by Sequencing | SARS coronavirus 2 whole genome | Seq | Pt | Isolate/Specimen | Nom | Sequencing | MICRO | 1 | SARS-CoV-2 genome Islt/Spm-Seq | ACTIVE | 2.69 | |
2.68 | 94763-0 | SARS-CoV-2 (COVID-19) [Presence] in Specimen by Organism specific culture | SARS coronavirus 2 | PrThr | Pt | XXX | Ord | Organism specific culture | MICRO | 1 | SARS-CoV-2 Spec Ql Cult | ACTIVE | 2.69 | |
2.68 | 94760-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Nasopharynx by NAA with probe detection | SARS coronavirus 2 N gene | PrThr | Pt | Nph | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 N gene Nph Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94759-8 | SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection | SARS coronavirus 2 RNA | PrThr | Pt | Nph | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA Nph Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94661-6 | SARS-CoV-2 (COVID-19) Ab [Interpretation] in Serum or Plasma | SARS coronavirus 2 Ab | Imp | Pt | Ser/Plas | Nom | MICRO | 1 | SARS-CoV-2 Ab SerPl-Imp | ACTIVE | 2.69 | ||
96797-6 | SARS-CoV-2 (COVID-19) RNA [Presence] in Oropharyngeal wash by NAA with probe detection | SARS coronavirus 2 RNA | PrThr | Pt | Oropharyngeal wash | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 RNA OPA wash Ql NAA+probe | ACTIVE | |||
2.68 | 94641-8 | SARS-CoV-2 (COVID-19) S gene [Presence] in Specimen by NAA with probe detection | SARS coronavirus 2 S gene | PrThr | Pt | XXX | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 S gene Spec Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94640-0 | SARS-CoV-2 (COVID-19) S gene [Presence] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 S gene | PrThr | Pt | Respiratory | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 S gene Resp Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94559-2 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Respiratory specimen by NAA with probe detection | SARS coronavirus 2 ORF1ab region | PrThr | Pt | Respiratory | Ord | Probe.amp.tar | MICRO | 1 | SARS-CoV-2 ORF1ab Resp Ql NAA+probe | ACTIVE | 2.69 | |
2.68 | 94558-4 | SARS-CoV-2 (COVID-19) Ag [Presence] in Respiratory specimen by Rapid immunoassay | SARS coronavirus 2 Ag | PrThr | Pt | Respiratory | Ord | IA.rapid | MICRO | 1 | SARS-CoV-2 Ag Resp Ql IA.rapid | ACTIVE | 2.69 | |
2.68 | 94306-8 | SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | SARS coronavirus 2 RNA panel | - | Pt | XXX | - | Probe.amp.tar | PANEL.MICRO | 1 | SARS-CoV-2 RNA Pnl Spec NAA+probe | ACTIVE | 2.69 |
LOINC terms for SARS-CoV-2 AOE questions
VersionFirstReleased | LOINC_NUM | Long Common Name | Component | Property | Time_Aspct | System | Scale_Typ | Method_Typ | Class | ClassType | Shortname | External_Copyright_Notice | Status | VersionLastChanged |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2.36 | 65222-2 | Date and time of symptom onset | Date and time of symptom onset | TmStp | Pt | ^Patient | Qn | H&P.PX | 2 | Date+time symptom onset | ACTIVE | 2.68 | ||
2.04 | 30525-0 | Age | Age | Time | Pt | ^Patient | Qn | MISC | 1 | Age | ACTIVE | 2.40 | ||
2.69 | 95417-2 | Whether this is the patient's first test for condition of interest | First test for condition of interest | Find | Pt | ^Patient | Ord | H&P.HX | 2 | First test for condition of interest | TRIAL | 2.69 | ||
2.69 | 95418-0 | Whether patient is employed in a healthcare setting | Employed in a healthcare setting | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Employed in healthcare setting | ACTIVE | 2.69 | ||
2.69 | 95419-8 | Whether the patient has symptoms related to condition of interest | Has symptoms related to condition of interest | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Has symptoms for condition | ACTIVE | 2.69 | ||
2.69 | 95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | Admitted to intensive care unit for condition of interest | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Admitted to ICU for condition | ACTIVE | 2.69 | ||
2.69 | 95421-4 | Whether patient resides in a congregate care setting | Resides in a congregate care setting | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Resides in a congregate care setting | ACTIVE | 2.69 | ||
2.52 | 77974-4 | Whether the patient was hospitalized for condition of interest | Hospitalized for condition of interest | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Hospitalized for condition | ACTIVE | 2.69 | ||
2.58 | 82810-3 | Pregnancy status | Pregnancy status | Find | Pt | ^Patient | Nom | H&P.HX | 2 | Pregnancy status | ACTIVE | 2.66 | ||
2.69 | 96553-3 | Date of subsequent report to public health department | Date of subsequent report to public health department | Date | Pt | ^Patient | Qn | PUBLICHEALTH | 2 | Subseq rpt date to PHD | ACTIVE | 2.69 |
Convalescent plasma
VersionFirstReleased | LOINC_NUM | Long Common Name | Component | Property | Time_Aspct | System | Scale_Typ | Method_Typ | Class | ClassType | Shortname | External_Copyright_Notice | Status | VersionLastChanged |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2.68 | 95355-4 | Convalescent plasma given [Volume] | Convalescent plasma given | Vol | Pt | ^Patient | Qn | BLDBK | 1 | Convl plasma Gvn Vol | ACTIVE | 2.68 | ||
2.68 | 95354-7 | Transfuse convalescent plasma [Volume] | Transfuse convalescent plasma | Vol | Pt | ^Patient | Qn | BLDBK | 1 | Trans Convl Plasma Vol | ACTIVE | 2.68 |
LOINC terms related to public health case reporting
VersionFirstReleased | LOINC_NUM | Long Common Name | Component | Property | Time_Aspct | System | Scale_Typ | Method_Typ | Class | ClassType | Shortname | External_Copyright_Notice | Status | VersionLastChanged |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2.36 | 65222-2 | Date and time of symptom onset | Date and time of symptom onset | TmStp | Pt | ^Patient | Qn | H&P.PX | 2 | Date+time symptom onset | ACTIVE | 2.68 | ||
2.50 | 75618-9 | Comorbid condition | Comorbid condition | Find | Pt | ^Patient | Nom | H&P.HX | 2 | Comorbid condition | ACTIVE | 2.70 | ||
2.68 | 94650-9 | Contact identifier Contact | Contact identifier | ID | Pt | ^Contact | Nom | ADMIN.ID | 2 | Contact ID Contact | ACTIVE | 2.68 | ||
2.68 | 94651-7 | Country of travel [Location] | Country of travel | Loc | Pt | ^Patient | Nom | H&P.HX | 2 | Country of trav | ACTIVE | 2.68 | ||
2.68 | 94652-5 | Known exposure date | Known exposure date | Date | Pt | ^Patient | Qn | H&P.HX | 2 | Exposure date | ACTIVE | 2.68 | ||
2.68 | 94653-3 | City of travel [Location] | City of travel | Loc | Pt | ^Patient | Nom | H&P.HX | 2 | City of trav | ACTIVE | 2.68 | ||
2.68 | 94654-1 | Known exposure panel | Known exposure panel | - | Pt | ^Patient | - | PANEL.H&P | 2 | Exposure pnl | ACTIVE | 2.68 | ||
2.68 | 94656-6 | State of known exposure | State of known exposure | Loc | Pt | ^Patient | Nom | H&P.HX | 2 | State of exposure | ACTIVE | 2.68 | ||
2.68 | 94657-4 | Contact case identifier | Case identifier | ID | Pt | ^Contact | Nom | ADMIN | 2 | Case ID Contact | ACTIVE | 2.68 | ||
2.68 | 94658-2 | City of known exposure | City of known exposure | Loc | Pt | ^Patient | Nom | H&P.HX | 2 | City of exposure | ACTIVE | 2.68 | ||
2.68 | 95386-9 | Date and time of most recent contact with confirmed case | Date and time of most recent contact with confirmed case | Date | Pt | ^Patient | Qn | H&P.PX | 2 | D/T most recent contact w case | ACTIVE | 2.69 | ||
2.69 | 96553-3 | Date of subsequent report to public health department | Date of subsequent report to public health department | Date | Pt | ^Patient | Qn | PUBLICHEALTH | 2 | Subseq rpt date to PHD | ACTIVE | 2.69 | ||
2.04 | 30525-0 | Age | Age | Time | Pt | ^Patient | Qn | MISC | 1 | Age | ACTIVE | 2.40 | ||
2.09 | 32624-9 | Race | Race | Type | Pt | ^Patient | Nom | CLIN | 2 | Race | ACTIVE | 2.40 | ||
2.21 | 48766-0 | Information source | Information source | Type | Pt | {system} | Nom | DOC.MISC | 2 | Source of info | ACTIVE | 2.66 | ||
2.29 | 56831-1 | Problem associated signs and symptoms | Problem associated signs and symptoms | Find | Pt | ^Patient | Nom | ED | 2 | Problem associated signs+symptoms | ACTIVE | 2.29 | ||
2.38 | 66455-7 | Condition status | Condition status | Find | Pt | ^Patient | Nom | PHENX | 2 | Condition status | ACTIVE | 2.64 | ||
2.40 | 71726-4 | Personnel Business phone number | Business phone number | Tele | Pt | Personnel | Nom | ADMIN | 2 | Personnel Business phone # | ACTIVE | 2.66 | ||
2.40 | 71728-0 | Personnel Email address | Email address | EmailAddr | Pt | Personnel | Nom | ADMIN | 2 | Personnel Email address | ACTIVE | 2.66 | ||
2.40 | 71739-7 | Personnel First name | First name | Pn | Pt | Personnel | Nom | ADMIN | 2 | Personnel First name | ACTIVE | 2.67 | ||
2.40 | 71740-5 | Personnel Last name | Last name | Pn | Pt | Personnel | Nom | ADMIN | 2 | Personnel Last name | ACTIVE | 2.67 | ||
2.48 | 74547-1 | Reporter email | Reporter email | EmailAddr | Pt | ^Event | Nom | SURVEY.AHRQ | 4 | ACTIVE | 2.48 | |||
2.48 | 74548-9 | Reporter phone number | Reporter phone number | Tele | Pt | ^Event | Nom | SURVEY.AHRQ | 4 | ACTIVE | 2.48 | |||
2.50 | 75617-1 | Residence [NAMCS] | Residence | Type | Pt | ^Patient | Nom | NAMCS | SURVEY.NHCS | 4 | ACTIVE | 2.52 | ||
2.07 | 31208-2 | Specimen source identified | Specimen source | Prid | Pt | XXX | Nom | SPEC | 1 | Specimen source | ACTIVE | 2.69 | ||
2.48 | 74549-7 | Reporter of adverse event or unsafe condition | Reporter of adverse event or unsafe condition | Pn | Pt | ^Event | Nom | SURVEY.AHRQ | 4 | ACTIVE | 2.48 | |||
2.52 | 77968-6 | National reporting jurisdiction | National reporting jurisdiction | Loc | Pt | ^Event | Nom | SURVEY.CDC | 4 | ACTIVE | 2.66 | |||
2.52 | 77974-4 | Whether the patient was hospitalized for condition of interest | Hospitalized for condition of interest | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Hospitalized for condition | ACTIVE | 2.69 | ||
2.52 | 77978-5 | Patient died from illness of interest | Patient died from illness of interest | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Pt died from illness | ACTIVE | 2.54 | ||
2.52 | 77994-2 | Date of first report to Centers for Disease Control and Prevention [CDC.PHIN] | Date of first report to Centers for Disease Control and Prevention | TmStp | Pt | ^Event | Qn | CDC.PHIN | SURVEY.CDC | 4 | ACTIVE | 2.52 | ||
2.52 | 77997-5 | Legacy case identifier [CDC.PHIN] | Legacy case identifier | ID | Pt | ^Event | Nom | CDC.PHIN | SURVEY.CDC | 4 | ACTIVE | 2.52 | ||
2.52 | 77999-1 | Case notification comment | Case notification comment | Imp | Pt | ^Event | Nom | SURVEY.CDC | 4 | ACTIVE | 2.52 | |||
2.54 | 80398-1 | Unique identifier for Current sample | Unique identifier | ID | Pt | Current sample | Nom | SPEC | 1 | Unique ID Current sample | ACTIVE | 2.68 | ||
2.58 | 82754-3 | State of travel | State of travel | Loc | Pt | ^Patient | Nom | H&P.HX | 2 | St of travel | ACTIVE | 2.58 | ||
2.58 | 82764-2 | Country of travel outside the U.S. [Location] 2 years | Country of travel outside the U.S. | Loc | 2Y | ^Patient | Nom | H&P.HX | 2 | Trav country outside U.S. 2Y | ACTIVE | 2.58 | ||
2.58 | 82810-3 | Pregnancy status | Pregnancy status | Find | Pt | ^Patient | Nom | H&P.HX | 2 | Pregnancy status | ACTIVE | 2.66 | ||
1.0h(3) | 8649-6 | Hospital discharge date | Hospital discharge date | TmStp | Pt | ^Patient | Qn | H&P.HX | 2 | Hospital discharge date | ACTIVE | 2.27 | ||
1.0h(3) | 8656-1 | Hospital admission date | Hospital admission date | TmStp | Pt | ^Patient | Qn | H&P.HX | 2 | Hospital admission date | ACTIVE | 2.27 | ||
2.64 | 88636-6 | Known exposure [Identifier] | Known exposure | Prid | Pt | ^Patient | Nom | H&P.HX | 2 | Known exposure | ACTIVE | 2.64 | ||
2.68 | 94544-4 | Exposure source in 30 days prior to onset of illness | Exposure source in 30D prior to onset of illness | Type | Pt | ^Patient | Nom | H&P.HX | 2 | Exp source 30D prior onset | ACTIVE | 2.68 | ||
2.68 | 94545-1 | Household contacts [#] | Household contacts | Num | Pt | ^Patient | Qn | ADMIN | 2 | Household contacts | ACTIVE | 2.68 | ||
2.68 | 94546-9 | Relationship to individual with confirmed or suspected illness | Relationship to individual with confirmed or suspected illness | Type | Pt | ^Patient | Nom | H&P.HX | 2 | Rel to ind w conf/susp ill | ACTIVE | 2.68 | ||
2.68 | 94655-8 | Identifier and Assigning authority panel | Identifier & Assigning authority panel | - | Pt | ^Patient | - | PANEL.ADMIN | 2 | ID & Authority panel | ACTIVE | 2.68 | ||
2.52 | 77966-0 | Reporting state | Reporting state | Loc | Pt | ^Event | Nom | SURVEY.CDC | 4 | ACTIVE | 2.70 | |||
2.52 | 77990-0 | Case class status [CDC.PHIN] | Case class status | Type | Pt | ^Event | Nom | CDC.PHIN | SURVEY.CDC | 4 | ACTIVE | 2.52 | ||
2.52 | 77996-7 | Pregnancy status at time of illness or condition | Pregnancy status at time of illness or condition | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Preg stat at illness cond | ACTIVE | 2.52 | ||
2.52 | 77998-3 | Age at time of case investigation | Age at time of case investigation | Time | Pt | ^Patient | Qn | SURVEY.CDC | 4 | ACTIVE | 2.52 | |||
2.56 | 81267-7 | Setting of exposure to illness | Setting of exposure to illness | Type | Pt | ^Patient | Nom | H&P.HX | 2 | Setting of exposure to illness | ACTIVE | 2.56 | ||
2.68 | 94659-0 | Case identifier | Case identifier | ID | Pt | ^Patient | Nom | ADMIN | 2 | Case ID | ACTIVE | 2.68 | ||
2.68 | 95364-6 | Personnel Organization | Organization | ID | Pt | Personnel | Nom | ADMIN | 2 | Personnel | ACTIVE | 2.68 | ||
2.68 | 95365-3 | Criteria used for case classification | Criteria used for case classification | Find | Pt | ^Patient | Nom | PUBLICHEALTH | 2 | Criteria for case classification | ACTIVE | 2.68 | ||
2.68 | 95366-1 | Date of first positive specimen collection | Date of first positive specimen collection | Date | Pt | ^Patient | Qn | SPEC | 1 | Dt of 1st pos specimen collection | ACTIVE | 2.68 | ||
2.68 | 95367-9 | Intensive care unit (ICU) admission date | Intensive care unit admission date | Date | Pt | ^Patient | Qn | H&P.HX | 2 | ICU admission date | ACTIVE | 2.69 | ||
2.68 | 95368-7 | Intensive care unit (ICU) discharge date | Intensive care unit discharge date | Date | Pt | ^Patient | Qn | H&P.HX | 2 | ICU discharge date | ACTIVE | 2.69 | ||
2.68 | 95369-5 | Affiliated with a tribe | Affiliated with a tribe | Find | Pt | ^Patient | Ord | ADMIN.DEMOG | 2 | Affiliated with tribe | ACTIVE | 2.68 | ||
2.68 | 95370-3 | Tribal affiliation | Tribal affiliation | Type | Pt | ^Patient | Nom | ADMIN.DEMOG | 2 | Tribal affiliation | ACTIVE | 2.68 | ||
2.68 | 95371-1 | Enrolled in a tribe | Enrolled in a tribe | Find | Pt | ^Patient | Ord | ADMIN.DEMOG | 2 | Enrolled tribe | ACTIVE | 2.68 | ||
2.68 | 95372-9 | Workplace setting | Workplace setting | Type | Pt | ^Patient | Nom | ADMIN.DEMOG | 2 | Workplace | ACTIVE | 2.68 | ||
2.68 | 95373-7 | Workplace is a part of critical infrastructure | Workplace is a part of critical infrastructure | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Workplace part of crit infrastructure | ACTIVE | 2.68 | ||
2.68 | 95374-5 | Critical infrastructure workplace setting | Critical infrastructure workplace setting | Type | Pt | ^Patient | Nom | H&P.HX | 2 | Crit infrastructure workplace type | ACTIVE | 2.68 | ||
2.68 | 95375-2 | Contact was with U.S. or international case | Contact was with U.S. or international case | Find | Pt | ^Patient | Nom | H&P.HX | 2 | Contact w/U.S. case | ACTIVE | 2.68 | ||
2.68 | 95376-0 | Type of animal exposed to | Type of animal exposed to | Type | Pt | ^Patient | Nom | H&P.HX | 2 | Type of animal exposed to | ACTIVE | 2.68 | ||
2.68 | 95377-8 | Disability type | Disability | Type | Pt | ^Patient | Nom | H&P.HX | 2 | Disability | ACTIVE | 2.68 | ||
2.68 | 95382-8 | Date and time of symptom resolution | Date and time of symptom resolution | TmStp | Pt | ^Patient | Qn | CLIN | 2 | D/T symptom resolution | ACTIVE | 2.68 | ||
2.68 | 95383-6 | Symptom resolution status | Symptom resolution status | Find | Pt | ^Patient | Ord | CLIN | 2 | Symptom res status | ACTIVE | 2.68 | ||
2.69 | 96539-2 | Whether the patient received mechanical ventilation for condition of interest | Mechanical ventilation for condition of interest | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Mech vent for condition | ACTIVE | 2.69 | ||
2.69 | 96540-0 | Whether the patient received ECMO for condition of interest | Extracorporeal membrane oxygenation for condition of interest | Find | Pt | ^Patient | Ord | H&P.HX | 2 | ECMO for condition | ACTIVE | 2.69 | ||
2.69 | 96541-8 | Patient is within 6 weeks postpartum | Patient is within 6 weeks postpartum | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Within 6 wks postpartum | ACTIVE | 2.69 | ||
2.69 | 96542-6 | Travel in 14 days prior to symptom onset | Travel in 14 days prior to symptom onset | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Travel 14D prior to symp | ACTIVE | 2.69 | ||
2.69 | 96543-4 | Visited healthcare facility in 14 days prior to symptom onset | Visited healthcare facility in 14 days prior to symptom onset | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Visit healthcare fac 14D prior to symp | ACTIVE | 2.69 | ||
2.69 | 96544-2 | Contact with confirmed case in 14 days prior to symptom onset | Contact with confirmed case in 14 days prior to symptom onset | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Cont w conf case 14D prior to symp | ACTIVE | 2.69 | ||
2.69 | 96545-9 | Date and time of first contact with confirmed case | Date and time of first contact with confirmed case | TmStp | Pt | ^Patient | Qn | H&P.HX | 2 | D/T first contact w case | ACTIVE | 2.69 | ||
2.69 | 96546-7 | Country where diagnosed | Country where diagnosed | Loc | Pt | ^Patient | Nom | PUBLICHEALTH | 2 | Country where dx | ACTIVE | 2.69 | ||
2.69 | 96547-5 | Province, state, or region where diagnosed | Province, state, or region where diagnosed | Loc | Pt | ^Patient | Nom | PUBLICHEALTH | 2 | Province, state or region where dx | ACTIVE | 2.69 | ||
2.69 | 96548-3 | Whether the patient was isolated per Infection Prevention and Control guidelines | Isolated per Infection Prevention and Control guidelines | Find | Pt | ^Patient | Ord | PUBLICHEALTH | 2 | Isolated per IPC guidelines | ACTIVE | 2.69 | ||
2.69 | 96549-1 | Date and time of infection control isolation | Date and time of infection control isolation | TmStp | Pt | ^Patient | Qn | PUBLICHEALTH | 2 | D/T infection cont isolation | ACTIVE | 2.69 | ||
2.69 | 96550-9 | Date of most recent lab test for condition of interest | Date of most recent lab test for condition of interest | Date | Pt | ^Patient | Qn | PUBLICHEALTH | 2 | Date latest lab test for cond of int | ACTIVE | 2.69 | ||
2.69 | 96551-7 | Number of contacts followed for contact tracing | Number of contacts followed for contact tracing | Num | Pt | ^Patient | Qn | PUBLICHEALTH | 2 | # contacts for contact tracing | ACTIVE | 2.69 | ||
2.69 | 96552-5 | Result of most recent lab test for condition of interest | Result of most recent lab test for condition of interest | Find | Pt | ^Patient | Nom | PUBLICHEALTH | 2 | Result latest lab test for cond of int | ACTIVE | 2.69 | ||
2.69 | 95418-0 | Whether patient is employed in a healthcare setting | Employed in a healthcare setting | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Employed in healthcare setting | ACTIVE | 2.69 | ||
2.69 | 95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | Admitted to intensive care unit for condition of interest | Find | Pt | ^Patient | Ord | H&P.HX | 2 | Admitted to ICU for condition | ACTIVE | 2.69 | ||
96988-1 | Vaccine CVX code | CVX code | ID | Pt | Vaccine | Nom | VACCIN | 2 | Vaccine CVX code | ACTIVE | ||||
96989-9 | Vaccine MVX code | MVX code | ID | Pt | Vaccine | Nom | VACCIN | 2 | Vaccine MVX code | ACTIVE | ||||
2.07 | 32418-6 | Obstetric trimester Stated | Obstetric trimester | Time | Pt | ^Patient | Ord | Stated | H&P.HX | 2 | OB trimester Stated | ACTIVE | 2.27 | |
2.38 | 67098-4 | Reason for test or procedure | Reason for test or procedure | Find | Pt | ^Patient | Nom | PHENX | 2 | Reason for test procedure | ACTIVE | 2.65 | ||
2.52 | 76689-9 | Sex assigned at birth | Sex assigned^at birth | Type | Pt | ^Patient | Nom | ADMIN.PATIENT.DEMOG | 2 | Sex assigned at birth | ACTIVE | 2.66 | ||
2.52 | 76696-4 | Name [Identifier] Facility | Name | ID | Pt | Facility | Nom | ADMIN.FACILITY | 2 | Name Facility | ACTIVE | 2.66 | ||
2.52 | 77983-5 | Country of usual residence [Location] | Country of usual residence | Loc | Pt | ^Patient | Nom | ADMIN.PATIENT.DEMOG | 2 | Country of usual residence | ACTIVE | 2.66 | ||
2.52 | 77984-3 | Country of exposure to illness [Location] | Country of exposure to illness | Loc | Pt | ^Patient | Nom | H&P.HX | 2 | Country exp to illness | ACTIVE | 2.54 | ||
2.54 | 80431-0 | Employer city | Employer city | Loc | Pt | ^Patient | Nom | ADMIN.PATIENT | 2 | Employer city | ACTIVE | 2.69 | ||
2.54 | 80437-7 | Employer country [Location] | Employer country | Loc | Pt | ^Patient | Nom | ADMIN.PATIENT | 2 | Employer country | ACTIVE | 2.69 | ||
2.68 | 94648-3 | Date contact confirmed as a case | Date of case confirmation | Date | Pt | ^Contact | Qn | PUBLICHEALTH | 2 | Date contact confirmed as case | ACTIVE | 2.68 | ||
2.68 | 94649-1 | Health department identifier | Health department | ID | Pt | Organization | Nom | ADMIN.FACILITY | 2 | Health dept ID | ACTIVE | 2.68 | ||
2.66 | 91560-3 | Date of departure from travel destination | Date of departure from travel destination | Date | Pt | ^Patient | Qn | H&P.HX | 2 | Date of departure from destination | ACTIVE | 2.66 | ||
2.66 | 91541-3 | Disease outcome [Type] | Disease outcome | Type | Pt | ^Patient | Nom | H&P.HX | 2 | Disease outcome Type | ACTIVE | 2.68 | ||
96998-0 | Count of people who are fully vaccinated in Population | People who are fully vaccinated | Num | Pt | ^Population | Qn | VACCIN | 2 | People who fully vaccinated Pop | ACTIVE | ||||
96997-2 | Count of people who initiated vaccination per 100,000 population | People who have received first dose of vaccine/100,000 population | NFr | Pt | ^Population | Qn | VACCIN | 2 | People rcvd first dose of vaccine/100,00 | ACTIVE | ||||
96996-4 | People who have received first dose of vaccine [#] Population | People who have received first dose of vaccine | Num | Pt | ^Population | Qn | VACCIN | 2 | People rcvd first dose of vaccine Pop | ACTIVE | ||||
96995-6 | Total vaccine doses distributed per 100,000 population | Vaccine doses distributed/100,000 population | NRto | Pt | ^Event | Qn | VACCIN | 2 | Vac doses dist per 100,000 | ACTIVE | ||||
97001-2 | Vaccine administration tier | Vaccine administration tier | Type | Pt | ^Event | Nom | VACCIN | 2 | Vaccine administration tier | ACTIVE | ||||
97000-4 | Vaccine doses distributed for use in long term care facilities [#] | Vaccine doses distributed for use in long term care facilities | Num | Pt | ^Event | Qn | VACCIN | 2 | Vaccine doses distributed to LTCFs | ACTIVE | ||||
96999-8 | Count of people who are fully vaccinated per 100,000 population | People who are fully vaccinated/100,000 population | NFr | Pt | ^Population | Qn | VACCIN | 2 | People who fully vaccinated/100,000 pop | ACTIVE | ||||
96994-9 | Vaccine doses distributed [#] | Vaccine doses distributed | Num | Pt | ^Event | Qn | VACCIN | 2 | Vaccine doses distributed | ACTIVE | ||||
96992-3 | State where vaccine was administered | Vaccine administration state | Loc | Pt | ^Event | Nom | VACCIN | 2 | Vaccine administration state | ACTIVE | ||||
96991-5 | Vaccine administration county [Location] | Vaccine administration county | Loc | Pt | ^Event | Nom | VACCIN | 2 | Vaccine administration county | ACTIVE | ||||
96990-7 | Vaccine administration location | Vaccine administration location | Type | Pt | ^Event | Nom | VACCIN | 2 | Vaccine administration loc | ACTIVE |
COVID and telehealth documents
VersionFirstReleased | LOINC_NUM | Long Common Name | Component | Property | Time_Aspct | System | Scale_Typ | Method_Typ | Class | ClassType | Shortname | External_Copyright_Notice | Status | VersionLastChanged |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2.69 | 95520-3 | Integrative medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Integrative medicine | DOC.ONTOLOGY | 2 | Integrative medicine Telehealth Note | ACTIVE | 2.69 | |
2.50 | 75496-0 | Telehealth Note | Note | Find | Pt | Telehealth | Doc | {Role} | DOC.ONTOLOGY | 2 | Telehealth Note | ACTIVE | 2.54 | |
2.50 | 75497-8 | Telehealth Progress note | Progress note | Find | Pt | Telehealth | Doc | {Role} | DOC.ONTOLOGY | 2 | Telehealth Progress note | ACTIVE | 2.58 | |
2.50 | 75498-6 | Telehealth Summary note | Summary note | Find | Pt | Telehealth | Doc | {Role} | DOC.ONTOLOGY | 2 | Telehealth Summary note | ACTIVE | 2.54 | |
2.58 | 84009-0 | Spinal cord injury medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Spinal cord injury medicine | DOC.ONTOLOGY | 2 | SCIM Telehealth Note | ACTIVE | 2.58 | |
2.58 | 84069-4 | Multi-specialty program Telehealth Summary note | Summary note | Find | Pt | Telehealth | Doc | Multi-specialty program | DOC.ONTOLOGY | 2 | Multi-spec prog Telehealth Summary note | ACTIVE | 2.58 | |
2.58 | 84070-2 | Multi-specialty program Telehealth Plan of care note | Plan of care note | Find | Pt | Telehealth | Doc | Multi-specialty program | DOC.ONTOLOGY | 2 | Mult-spec prg Telehlth Plan of care note | ACTIVE | 2.58 | |
2.58 | 84215-3 | Mental health Telehealth Note | Note | Find | Pt | Telehealth | Doc | Mental health | DOC.ONTOLOGY | 2 | Mental health Telehealth Note | ACTIVE | 2.58 | |
2.58 | 84231-0 | Neurology Telehealth Consult note | Consultation note | Find | Pt | Telehealth | Doc | Neurology | DOC.ONTOLOGY | 2 | Neurology Telehealth Consult note | ACTIVE | 2.58 | |
2.58 | 84232-8 | Neurology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Neurology | DOC.ONTOLOGY | 2 | Neurology Telehealth Note | ACTIVE | 2.58 | |
2.58 | 84233-6 | Neurology Telehealth Initial evaluation note | Initial evaluation note | Find | Pt | Telehealth | Doc | Neurology | DOC.ONTOLOGY | 2 | Neurology Telehealth Initial eval note | ACTIVE | 2.58 | |
2.58 | 84274-0 | Nurse Telehealth Note | Note | Find | Pt | Telehealth | Doc | Nurse | DOC.ONTOLOGY | 2 | Nurse Telehealth Note | ACTIVE | 2.58 | |
2.58 | 85206-1 | Telehealth Initial evaluation note | Initial evaluation note | Find | Pt | Telehealth | Doc | {Role} | DOC.ONTOLOGY | 2 | Telehealth Initial eval note | ACTIVE | 2.58 | |
2.58 | 85207-9 | Telehealth Education note | Education note | Find | Pt | Telehealth | Doc | {Role} | DOC.ONTOLOGY | 2 | Telehealth Educ note | ACTIVE | 2.58 | |
2.58 | 85208-7 | Telehealth Consult note | Consultation note | Find | Pt | Telehealth | Doc | {Role} | DOC.ONTOLOGY | 2 | Telehealth Consult note | ACTIVE | 2.58 | |
2.61 | 85888-6 | Multi-specialty program Telehealth Note | Note | Find | Pt | Telehealth | Doc | Multi-specialty program | DOC.ONTOLOGY | 2 | Multi-spec prog Telehealth Note | ACTIVE | 2.61 | |
2.61 | 86208-6 | Cardiology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Cardiovascular disease | DOC.ONTOLOGY | 2 | Cardiology Telehealth Note | ACTIVE | 2.61 | |
2.64 | 89031-9 | Hematology Telehealth Consult note | Consultation note | Find | Pt | Telehealth | Doc | Hematology | DOC.ONTOLOGY | 2 | Hematology Telehealth Consult note | ACTIVE | 2.64 | |
2.64 | 89032-7 | Nephrology Telehealth Consult note | Consultation note | Find | Pt | Telehealth | Doc | Nephrology | DOC.ONTOLOGY | 2 | Nephrology Telehealth Consult note | ACTIVE | 2.64 | |
2.64 | 89033-5 | Urology Telehealth Consult note | Consultation note | Find | Pt | Telehealth | Doc | Urology | DOC.ONTOLOGY | 2 | Urology Telehealth Consult note | ACTIVE | 2.64 | |
2.65 | 89883-3 | Emergency medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Emergency medicine | DOC.ONTOLOGY | 2 | Emergency med Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89884-1 | Hematology+Medical oncology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Hematology+Medical oncology | DOC.ONTOLOGY | 2 | HemOnc Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89885-8 | Pain medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Pain medicine | DOC.ONTOLOGY | 2 | Pain medicine Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89886-6 | Palliative care Telehealth Note | Note | Find | Pt | Telehealth | Doc | Palliative care | DOC.ONTOLOGY | 2 | Palliative care Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89887-4 | Adolescent medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Adolescent medicine | DOC.ONTOLOGY | 2 | Adolescent med Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89888-2 | Pediatrics Telehealth Note | Note | Find | Pt | Telehealth | Doc | Pediatrics | DOC.ONTOLOGY | 2 | Peds Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89889-0 | Physical medicine and rehab Telehealth Note | Note | Find | Pt | Telehealth | Doc | Physical medicine and rehab | DOC.ONTOLOGY | 2 | PM+R Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89890-8 | Diabetology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Diabetology | DOC.ONTOLOGY | 2 | Diabetology Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89891-6 | Endocrinology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Endocrinology | DOC.ONTOLOGY | 2 | Endocrinology Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89892-4 | Infectious disease Telehealth Note | Note | Find | Pt | Telehealth | Doc | Infectious disease | DOC.ONTOLOGY | 2 | Infectious disease Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89893-2 | Clinical genetics Telehealth Note | Note | Find | Pt | Telehealth | Doc | Clinical genetics | DOC.ONTOLOGY | 2 | Clinical genetics Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89894-0 | Neonatal perinatal medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Neonatal perinatal medicine | DOC.ONTOLOGY | 2 | Neo peri med Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89895-7 | Allergy and Immunology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Allergy+Immunology | DOC.ONTOLOGY | 2 | Allergy+Immunology Telehealth Note | ACTIVE | 2.66 | |
2.65 | 89896-5 | Developmental-behavioral pediatrics Telehealth Note | Note | Find | Pt | Telehealth | Doc | Developmental-behavioral pediatrics | DOC.ONTOLOGY | 2 | Develop-behav peds Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89897-3 | Gynecology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Gynecology | DOC.ONTOLOGY | 2 | Gynecology Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89898-1 | Nephrology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Nephrology | DOC.ONTOLOGY | 2 | Nephrology Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89899-9 | Orthopaedic surgery Telehealth Note | Note | Find | Pt | Telehealth | Doc | Orthopaedic surgery | DOC.ONTOLOGY | 2 | Orthopaedic surgery Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89900-5 | Rheumatology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Rheumatology | DOC.ONTOLOGY | 2 | Rheumatology Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89901-3 | Sports medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Sports medicine | DOC.ONTOLOGY | 2 | Sports medicine Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89902-1 | Otolaryngology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Otolaryngology | DOC.ONTOLOGY | 2 | Otolaryngology Telehealth Note | ACTIVE | 2.65 | |
2.65 | 89903-9 | Urology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Urology | DOC.ONTOLOGY | 2 | Urology Telehealth Note | ACTIVE | 2.65 | |
2.65 | 90008-4 | Pharmacogenomics Telehealth Note | Note | Find | Pt | Telehealth | Doc | Pharmacogenomics | DOC.ONTOLOGY | 2 | Pharmacogenomics Telehealth Note | ACTIVE | 2.65 | |
2.65 | 90712-1 | Sleep medicine Telehealth Consult note | Consultation note | Find | Pt | Telehealth | Doc | Sleep medicine | DOC.ONTOLOGY | 2 | Sleep med Telehealth Consult note | ACTIVE | 2.65 | |
2.68 | 94821-6 | COVID-19 Intubation advance directives | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Intubation Adv Dir | ACTIVE | 2.68 | |
2.68 | 95407-3 | Cardiopulmonary Telehealth Note | Note | Find | Pt | Telehealth | Doc | Cardiovascular disease+Pulmonary disease | DOC.ONTOLOGY | 2 | Cardio+Pulm disease Telehealth Note | ACTIVE | 2.68 | |
2.68 | 95412-3 | COVID-19 case report | COVID19 case report | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Case rprt | ACTIVE | 2.68 | |
2.68 | 95381-0 | Telephone encounter COVID-19 note | COVID19 note | Find | Pt | Telephone encounter | Doc | {Role} | DOC.ONTOLOGY | 2 | Phone COVID19 note | ACTIVE | 2.68 | |
2.69 | 95804-1 | Breastfeeding Telehealth Note | Note | Find | Pt | Telehealth | Doc | Breastfeeding | DOC.ONTOLOGY | 2 | Breastfeeding Telehealth Note | ACTIVE | 2.69 | |
2.65 | 90713-9 | Sleep medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Sleep medicine | DOC.ONTOLOGY | 2 | Sleep med Telehealth Note | ACTIVE | 2.65 | |
2.65 | 90714-7 | Pain medicine Telehealth Consult note | Consultation note | Find | Pt | Telehealth | Doc | Pain medicine | DOC.ONTOLOGY | 2 | Pain medicine Telehealth Consult note | ACTIVE | 2.65 | |
2.65 | 90715-4 | Palliative care Telehealth Consult note | Consultation note | Find | Pt | Telehealth | Doc | Palliative care | DOC.ONTOLOGY | 2 | Palliative care Telehealth Consult note | ACTIVE | 2.65 | |
2.65 | 90716-2 | Psychiatry Telehealth Note | Note | Find | Pt | Telehealth | Doc | Psychiatry | DOC.ONTOLOGY | 2 | Psychiatric Telehealth Note | ACTIVE | 2.65 | |
2.66 | 91531-4 | Social worker Telehealth Note | Note | Find | Pt | Telehealth | Doc | Social worker | DOC.ONTOLOGY | 2 | SW Telehealth Note | ACTIVE | 2.66 | |
2.66 | 92913-3 | Immunology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Immunology | DOC.ONTOLOGY | 2 | Immunology Telehealth Note | ACTIVE | 2.66 | |
2.68 | 94594-9 | Neurological surgery Telehealth Note | Note | Find | Pt | Telehealth | Doc | Neurological surgery | DOC.ONTOLOGY | 2 | Neuro surgery Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94595-6 | Pharmacology Telehealth Medication management note | Medication management note | Find | Pt | Telehealth | Doc | Pharmacology | DOC.ONTOLOGY | 2 | Pharmacology Telehealth Med mgmt note | ACTIVE | 2.68 | |
2.68 | 94721-8 | COVID-19 Evaluation note | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Eval note | ACTIVE | 2.68 | |
2.68 | 94722-6 | COVID-19 Initial Evaluation form | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Initial Eval form | ACTIVE | 2.68 | |
2.68 | 94723-4 | Emergency department COVID-19 Initial Evaluation form | COVID19+ |
Find | Pt | Emergency department | Doc | {Role} | DOC.ONTOLOGY | 2 | ED COVID19 Initial Eval form | ACTIVE | 2.68 | |
2.68 | 94724-2 | Pulmonary Telehealth Note | Note | Find | Pt | Telehealth | Doc | Pulmonary disease | DOC.ONTOLOGY | 2 | Pulmonary disease Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94725-9 | Aerodigestive medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Aerodigestive medicine | DOC.ONTOLOGY | 2 | Aerodigestive med Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94726-7 | Cleft and Craniofacial Telehealth Note | Note | Find | Pt | Telehealth | Doc | Cleft and Craniofacial | DOC.ONTOLOGY | 2 | Cleft+Craniofacial Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94770-5 | Wound, Ostomy, and Continence Care Telehealth Note | Note | Find | Pt | Telehealth | Doc | Wound, ostomy, and continence care | DOC.ONTOLOGY | 2 | WOC Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94771-3 | Anesthesiology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Anesthesiology | DOC.ONTOLOGY | 2 | Anesthesiology Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94772-1 | Blood banking and transfusion medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Blood banking and transfusion medicine | DOC.ONTOLOGY | 2 | Bld Bnk+Trans Med Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94773-9 | Burn management Telehealth Note | Note | Find | Pt | Telehealth | Doc | Burn management | DOC.ONTOLOGY | 2 | Burn Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94774-7 | Cardiac surgery Telehealth Note | Note | Find | Pt | Telehealth | Doc | Cardiac surgery | DOC.ONTOLOGY | 2 | Cardiac surgery Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94775-4 | Critical care medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Critical Care Medicine | DOC.ONTOLOGY | 2 | CCM Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94776-2 | Dentistry Telehealth Note | Note | Find | Pt | Telehealth | Doc | Dentistry | DOC.ONTOLOGY | 2 | Dentistry Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94777-0 | Dermatology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Dermatology | DOC.ONTOLOGY | 2 | Dermatology Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94778-8 | Ethics Telehealth Note | Note | Find | Pt | Telehealth | Doc | Ethics | DOC.ONTOLOGY | 2 | Ethics Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94779-6 | Family medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Family medicine | DOC.ONTOLOGY | 2 | Fam Med Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94780-4 | Gastroenterology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Gastroenterology | DOC.ONTOLOGY | 2 | Gastroenterology Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94781-2 | General medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | General medicine | DOC.ONTOLOGY | 2 | General medicine Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94782-0 | Surgery Telehealth Note | Note | Find | Pt | Telehealth | Doc | Surgery | DOC.ONTOLOGY | 2 | Surgery Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94783-8 | Geriatric medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Geriatric medicine | DOC.ONTOLOGY | 2 | Geri med Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94784-6 | Gynecologic oncology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Gynecologic oncology | DOC.ONTOLOGY | 2 | Gyn Onc Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94785-3 | Healthcare navigator Telehealth Note | Note | Find | Pt | Telehealth | Doc | Healthcare navigator | DOC.ONTOLOGY | 2 | Navigator Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94786-1 | Hematology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Hematology | DOC.ONTOLOGY | 2 | Hematology Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94787-9 | Interventional radiology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Interventional radiology | DOC.ONTOLOGY | 2 | IR Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94788-7 | Clinical pathology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Clinical pathology | DOC.ONTOLOGY | 2 | Clin Path Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94789-5 | Maternal and fetal medicine Telehealth Note | Note | Find | Pt | Telehealth | Doc | Maternal and fetal medicine | DOC.ONTOLOGY | 2 | Maternal fetal med Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94790-3 | Nutrition and dietetics Telehealth Note | Note | Find | Pt | Telehealth | Doc | Nutrition and dietetics | DOC.ONTOLOGY | 2 | Nutr+diet Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94791-1 | Occupational therapy Telehealth Note | Note | Find | Pt | Telehealth | Doc | Occupational therapy | DOC.ONTOLOGY | 2 | OT Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94792-9 | Oncology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Oncology | DOC.ONTOLOGY | 2 | Oncology Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94793-7 | Wound care management Telehealth Note | Note | Find | Pt | Telehealth | Doc | Wound care management | DOC.ONTOLOGY | 2 | Wound care management Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94794-5 | Ophthalmology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Ophthalmology | DOC.ONTOLOGY | 2 | Ophthalmol Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94795-2 | Pastoral care Telehealth Note | Note | Find | Pt | Telehealth | Doc | Pastoral care | DOC.ONTOLOGY | 2 | Pastoral Care Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94796-0 | Pharmacology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Pharmacology | DOC.ONTOLOGY | 2 | Pharmacology Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94797-8 | Plastic surgery Telehealth Note | Note | Find | Pt | Telehealth | Doc | Plastic surgery | DOC.ONTOLOGY | 2 | Plastic surgery Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94798-6 | Psychology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Psychology | DOC.ONTOLOGY | 2 | Psych Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94799-4 | Radiation oncology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Radiation oncology | DOC.ONTOLOGY | 2 | Radiation Onc Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94800-0 | Rapid response team Telehealth Note | Note | Find | Pt | Telehealth | Doc | Rapid response team | DOC.ONTOLOGY | 2 | Rapid response team Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94801-8 | Recreational therapy Telehealth Note | Note | Find | Pt | Telehealth | Doc | Recreational therapy | DOC.ONTOLOGY | 2 | Rec therapy Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94802-6 | Respiratory therapy Telehealth Note | Note | Find | Pt | Telehealth | Doc | Respiratory therapy | DOC.ONTOLOGY | 2 | Resp therapy Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94803-4 | Speech-language pathology Telehealth Note | Note | Find | Pt | Telehealth | Doc | Speech-language pathology | DOC.ONTOLOGY | 2 | Speech-lang path Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94804-2 | Trauma Telehealth Note | Note | Find | Pt | Telehealth | Doc | Trauma | DOC.ONTOLOGY | 2 | Trauma Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94805-9 | Vascular surgery Telehealth Note | Note | Find | Pt | Telehealth | Doc | Vascular surgery | DOC.ONTOLOGY | 2 | Vascular surgery Telehealth Note | ACTIVE | 2.68 | |
2.68 | 94806-7 | COVID-19 Intubation Consultation note | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Intub+Consult | ACTIVE | 2.69 | |
2.68 | 94807-5 | Attending COVID-19 Intubation Consultation note | COVID19+ |
Find | Pt | {Setting} | Doc | Attending | DOC.ONTOLOGY | 2 | Attend COVID19 Intub+Consult | ACTIVE | 2.69 | |
2.68 | 94808-3 | Resident COVID-19 Intubation Consultation note | COVID19+ |
Find | Pt | {Setting} | Doc | Resident | DOC.ONTOLOGY | 2 | Res COVID19 Intub+Consult | ACTIVE | 2.69 | |
2.68 | 94809-1 | COVID-19 Intubation Progress note | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Intub+Progress | ACTIVE | 2.69 | |
2.68 | 94810-9 | COVID-19 Intubation Procedure note | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Intub Proced | ACTIVE | 2.68 | |
2.68 | 94811-7 | COVID-19 Intubation Evaluation note | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Intub Eval note | ACTIVE | 2.68 | |
2.68 | 94812-5 | COVID-19 Intubation and Cardiopulmonary resuscitation note | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Intub+CPR | ACTIVE | 2.68 | |
2.68 | 94813-3 | Team COVID-19 Intubation Conference note | COVID19+ |
Find | Pt | {Setting} | Doc | Team | DOC.ONTOLOGY | 2 | Team COVID19 Intub Conference | ACTIVE | 2.68 | |
2.68 | 94814-1 | Critical care medicine COVID-19 Consultation note | COVID19+ |
Find | Pt | {Setting} | Doc | Critical Care Medicine | DOC.ONTOLOGY | 2 | CCM COVID19 Consult note | ACTIVE | 2.69 | |
96874-3 | COVID-19 Immunization note | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Immunization note | ACTIVE | |||
96736-4 | COVID-19 Procedure note | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Proced note | ACTIVE | |||
96737-2 | COVID-19 Consultation note | COVID19+ |
Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 Consult note | ACTIVE | |||
96738-0 | COVID-19 letter | COVID19 letter | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 letter | ACTIVE | |||
96739-8 | Telehealth COVID-19 note | COVID19 note | Find | Pt | Telehealth | Doc | {Role} | DOC.ONTOLOGY | 2 | Telehealth COVID19 note | ACTIVE | |||
96740-6 | COVID-19 note | COVID19 note | Find | Pt | {Setting} | Doc | {Role} | DOC.ONTOLOGY | 2 | COVID19 note | ACTIVE |